These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15823980)

  • 21. Sex differences in cognitive functioning in velocardiofacial syndrome (VCFS).
    Antshel KM; AbdulSabur N; Roizen N; Fremont W; Kates WR
    Dev Neuropsychol; 2005; 28(3):849-69. PubMed ID: 16266252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration of functional brain architecture in 22q11.2 deletion syndrome - Insights into susceptibility for psychosis.
    Larsen KM; Dzafic I; Siebner HR; Garrido MI
    Neuroimage; 2019 Apr; 190():154-171. PubMed ID: 30195053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Executive functions and memory abilities in children with 22q11.2 deletion syndrome.
    Campbell LE; Azuma R; Ambery F; Stevens A; Smith A; Morris RG; Murphy DG; Murphy KC
    Aust N Z J Psychiatry; 2010 Apr; 44(4):364-71. PubMed ID: 20307169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroanatomical underpinnings of autism symptomatology in carriers and non-carriers of the 22q11.2 microdeletion.
    Gudbrandsen M; Bletsch A; Mann C; Daly E; Murphy CM; Stoencheva V; Blackmore CE; Rogdaki M; Kushan L; Bearden CE; Murphy DGM; Craig MC; Ecker C
    Mol Autism; 2020 Jun; 11(1):46. PubMed ID: 32513259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noncompaction is already known in DiGeorge anomaly from 22q11.2 deletion.
    Stöllberger C; Finsterer J
    Am J Med Genet A; 2011 Mar; 155A(3):662-3; author reply 664-5. PubMed ID: 21337687
    [No Abstract]   [Full Text] [Related]  

  • 26. [Spectrum of neuropsychiatric features associated with velocardiofacial syndrome (Deletion 22q11.2)].
    Sieberer M; Runte I; Wilkening A; Pabst B; Ziegenbein M; Haltenhof H
    Fortschr Neurol Psychiatr; 2006 May; 74(5):263-74. PubMed ID: 16758538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catechol-O-methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11.2 deletion syndrome.
    Takarae Y; Schmidt L; Tassone F; Simon TJ
    Cogn Affect Behav Neurosci; 2009 Mar; 9(1):83-90. PubMed ID: 19246329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three phases of DiGeorge/22q11 deletion syndrome pathogenesis during brain development: patterning, proliferation, and mitochondrial functions of 22q11 genes.
    Meechan DW; Maynard TM; Tucker ES; LaMantia AS
    Int J Dev Neurosci; 2011 May; 29(3):283-94. PubMed ID: 20833244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of COMT genotype on behavioral symptomatology in the 22q11.2 Deletion Syndrome.
    Bearden CE; Jawad AF; Lynch DR; Monterossso JR; Sokol S; McDonald-McGinn DM; Saitta SC; Harris SE; Moss E; Wang PP; Zackai E; Emanuel BS; Simon TJ
    Child Neuropsychol; 2005 Feb; 11(1):109-17. PubMed ID: 15846854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neurocognitive phenotype in velo-cardio-facial syndrome: a developmental perspective.
    Antshel KM; Fremont W; Kates WR
    Dev Disabil Res Rev; 2008; 14(1):43-51. PubMed ID: 18636636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease.
    Staple L; Andrews T; McDonald-McGinn D; Zackai E; Sullivan KE
    Pediatr Allergy Immunol; 2005 May; 16(3):226-30. PubMed ID: 15853951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral and Psychiatric Phenotypes in 22q11.2 Deletion Syndrome.
    Tang KL; Antshel KM; Fremont WP; Kates WR
    J Dev Behav Pediatr; 2015 Oct; 36(8):639-50. PubMed ID: 26372046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genes, cognition, and language: some notes regarding velocardiofacial syndrome].
    Benítez A
    Neurologia; 2009; 24(1):50-8. PubMed ID: 19214817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion 22q11: spectrum of associated disorders.
    Hay BN
    Semin Pediatr Neurol; 2007 Sep; 14(3):136-9. PubMed ID: 17980310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
    Prasad SE; Howley S; Murphy KC
    Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroradiographic findings in 22q11.2 deletion syndrome.
    Bohm LA; Zhou TC; Mingo TJ; Dugan SL; Patterson RJ; Sidman JD; Roby BB
    Am J Med Genet A; 2017 Aug; 173(8):2158-2165. PubMed ID: 28577347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction: advances in research on velo-cardio-facial syndrome/22q11.2 deletion syndrome.
    Kates WR; Emanuel BS
    Dev Disabil Res Rev; 2008; 14(1):1-2. PubMed ID: 18636630
    [No Abstract]   [Full Text] [Related]  

  • 39. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome.
    Shashi V; Keshavan MS; Howard TD; Berry MN; Basehore MJ; Lewandowski E; Kwapil TR
    Clin Genet; 2006 Mar; 69(3):234-8. PubMed ID: 16542388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal patterns of cortical gyrification in velo-cardio-facial syndrome (deletion 22q11.2): an MRI study.
    Schaer M; Schmitt JE; Glaser B; Lazeyras F; Delavelle J; Eliez S
    Psychiatry Res; 2006 Jan; 146(1):1-11. PubMed ID: 16388934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.